Is this the outcome people expected, not least after almost five years? It makes the sudden urgency that so many now demand very odd. Given that the current trajectory means no change for the vast majority of new therapies, why the urgency?
Helpful evidence of how the review is landing on outcomes to potentially benefit a few 'Unicorns'
June 1, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
TGA provisional approval brings first targeted treatment for SOD1 linked ALS to Australia
June 1, 2026 - - Latest News -
Helpful evidence of how the review is landing on outcomes to potentially benefit a few 'Unicorns'
June 1, 2026 - - Latest News -
Australia's HTA Review closed-loop process continues with 'Delphi' stage two
June 1, 2026 - - Latest News -
New Zealand's pre-election Budget boosts health spending, but Pharmac misses out
May 29, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 29 May
May 28, 2026 - - Podcast -
AusBiotech unites conferences under the banner of the 'Biggest Week' in biotech
May 28, 2026 - - Australian Biotech -
Research highlighting gaps leaving some communities at greater risk as flu
May 28, 2026 - - Latest News
